Bronte Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-19,856	Closed	-$9.23M	–	25
2024 Q3	$9.23M	Buy	19,856 +37	+0.2%	+$17.2K	0.75%	19
2024 Q2	$9.29M	Sell	19,819 -798	-4%	-$374K	0.73%	20
2024 Q1	$8.62M	Sell	20,617 -143	-0.7%	-$59.8K	0.7%	22
2023 Q4	$8.45M	Buy	+20,760	New	+$8.45M	0.75%	21